GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
Date Action Amount Person Type
Jul 01, 2024 Buy 25 500 Pitukcheewanont Pisit Duke Stock Option (Right to Buy)
Feb 01, 2024 Buy 3 333 Pitukcheewanont Pisit Duke Stock Option (Right to Buy)
Jan 04, 2024 Buy 0 Pitukcheewanont Pisit Duke Common Stock
Aug 02, 2023 Sell 3 407 Mckew John C. Common Stock
Aug 01, 2023 Sell 1 593 Mckew John C. Common Stock
Aug 01, 2023 Sell 229 Lawley Lori D Common Stock
Jun 01, 2023 Buy 29 750 Pitukcheewanont Pisit Duke Stock Option (Right to Buy)
May 10, 2023 Buy 3 345 Zoth Lota S. Stock Option (Right to Buy)
May 10, 2023 Buy 3 345 Van Es-johansson An Stock Option (Right to Buy)
May 10, 2023 Buy 3 345 Raffin Thomas A. Stock Option (Right to Buy)
May 10, 2023 Buy 3 345 Mccracken Joseph S Stock Option (Right to Buy)
May 10, 2023 Buy 3 345 Lalande Kevin M. Stock Option (Right to Buy)
May 10, 2023 Buy 3 345 Johnson Chad Allen Stock Option (Right to Buy)
Apr 04, 2023 Sell 2 214 Mckew John C. Common Stock
Apr 01, 2023 Sell 342 Powers Bradley J Common Stock
Apr 01, 2023 Sell 1 036 Mckew John C. Common Stock
Apr 01, 2023 Sell 274 Lawley Lori D Common Stock
Apr 01, 2023 Sell 1 522 Hawkins Richard J Common Stock
Feb 02, 2023 Sell 439 Mckew John C. Common Stock
Feb 01, 2023 Buy 12 000 Schuchart Aaron Stock Option (Right to Buy)
Feb 01, 2023 Buy 1 000 Schuchart Aaron Common Stock
Feb 01, 2023 Sell 104 Schuchart Aaron Common Stock
Feb 01, 2023 Buy 11 000 Powers Bradley J Stock Option (Right to Buy)
Feb 01, 2023 Buy 900 Powers Bradley J Common Stock
Feb 01, 2023 Sell 131 Powers Bradley J Common Stock
Feb 01, 2023 Buy 2 000 Mckew John C. Common Stock
Feb 01, 2023 Sell 206 Mckew John C. Common Stock
Feb 01, 2023 Buy 16 000 Mckew John C. Stock Option (Right to Buy)
Feb 01, 2023 Buy 12 000 Lawley Lori D Stock Option (Right to Buy)
Feb 01, 2023 Buy 1 000 Lawley Lori D Common Stock
Feb 01, 2023 Sell 114 Lawley Lori D Common Stock
Feb 01, 2023 Buy 12 000 Karpf David B Stock Option (Right to Buy)
Feb 01, 2023 Buy 1 000 Karpf David B Common Stock
Feb 01, 2023 Sell 36 Karpf David B Common Stock
Feb 01, 2023 Buy 4 500 Hawkins Richard J Common Stock
Feb 01, 2023 Sell 416 Hawkins Richard J Common Stock
Feb 01, 2023 Buy 35 400 Hawkins Richard J Stock Option (Right to Buy)
Nov 16, 2022 Buy 4 000 Mccracken Joseph S Common Stock
Sep 23, 2022 Buy 208 Hawkins Richard J Common Stock
Sep 21, 2022 Buy 2 214 Hawkins Richard J Common Stock
Sep 20, 2022 Buy 1 506 Hawkins Richard J Common Stock
Sep 19, 2022 Buy 541 Hawkins Richard J Common Stock
Sep 01, 2022 Buy 42 500 Karpf David B Stock Option (Right to Buy)
Feb 01, 2022 Buy 12 000 Schuchart Aaron Stock Option (Right to Buy)
Feb 01, 2022 Buy 1 000 Schuchart Aaron Common Stock
Feb 01, 2022 Sell 52 Schuchart Aaron Common Stock
Feb 01, 2022 Buy 11 000 Powers Bradley J Stock Option (Right to Buy)
Feb 01, 2022 Buy 900 Powers Bradley J Common Stock
Feb 01, 2022 Sell 78 Powers Bradley J Common Stock
Feb 01, 2022 Buy 1 500 Mckew John C. Common Stock
Feb 01, 2022 Sell 100 Mckew John C. Common Stock
Feb 01, 2022 Buy 14 000 Mckew John C. Stock Option (Right to Buy)
Feb 01, 2022 Buy 12 000 Lawley Lori D Stock Option (Right to Buy)
Feb 01, 2022 Buy 1 000 Lawley Lori D Common Stock
Feb 01, 2022 Sell 65 Lawley Lori D Common Stock
Feb 01, 2022 Buy 400 Karpf David B Common Stock
Feb 01, 2022 Buy 5 000 Karpf David B Stock Option (Right to Buy)
Sep 08, 2021 Sell 2 214 Mckew John C. Common Stock
Sep 08, 2021 Buy 10 000 Lalande Kevin M. Common Stock
Sep 07, 2021 Buy 10 000 Lalande Kevin M. Common Stock
Sep 03, 2021 Buy 8 100 Lalande Kevin M. Common Stock
Sep 02, 2021 Buy 6 300 Lalande Kevin M. Common Stock
Sep 01, 2021 Buy 0 Karpf David B Common Stock
Sep 01, 2021 Buy 4 589 Lalande Kevin M. Common Stock
Aug 31, 2021 Buy 6 000 Lalande Kevin M. Common Stock
Aug 30, 2021 Buy 8 625 Lalande Kevin M. Common Stock
Aug 27, 2021 Buy 4 981 Lalande Kevin M. Common Stock
Aug 26, 2021 Buy 6 200 Lalande Kevin M. Common Stock
Aug 25, 2021 Buy 14 900 Lalande Kevin M. Common Stock
Aug 24, 2021 Buy 10 775 Lalande Kevin M. Common Stock
Aug 23, 2021 Buy 37 800 Lalande Kevin M. Common Stock
Aug 20, 2021 Buy 35 679 Lalande Kevin M. Common Stock
Aug 19, 2021 Buy 20 000 Lalande Kevin M. Common Stock
Aug 18, 2021 Buy 28 870 Lalande Kevin M. Common Stock
Aug 17, 2021 Buy 16 000 Lalande Kevin M. Common Stock
Aug 16, 2021 Buy 31 000 Lalande Kevin M. Common Stock
Aug 13, 2021 Buy 31 000 Lalande Kevin M. Common Stock
Aug 12, 2021 Buy 31 000 Lalande Kevin M. Common Stock
Aug 12, 2021 Buy 1 700 Schuchart Aaron Common Stock
Aug 11, 2021 Buy 300 Schuchart Aaron Common Stock
Aug 11, 2021 Buy 7 475 Mccracken Joseph S Common Stock
Aug 01, 2021 Buy 20 000 Mckew John C. Common Stock
Aug 01, 2021 Buy 21 250 Lawley Lori D Stock Option (Right to Buy)
Aug 01, 2021 Buy 3 750 Lawley Lori D Common Stock
Jun 01, 2021 Buy 7 805 Schuchart Aaron Stock Option (Right to Buy)
May 20, 2021 Buy 2 910 Zoth Lota S. Stock Option (Right to Buy)
May 20, 2021 Buy 367 Zoth Lota S. Common Stock
May 20, 2021 Buy 367 Raffin Thomas A. Common Stock
May 20, 2021 Buy 2 910 Raffin Thomas A. Stock Option (Right to Buy)
May 20, 2021 Buy 2 910 Mccracken Joseph S Stock Option (Right to Buy)
May 20, 2021 Buy 367 Mccracken Joseph S Common Stock
May 20, 2021 Buy 2 910 Lalande Kevin M. Stock Option (Right to Buy)
May 20, 2021 Buy 367 Lalande Kevin M. Common Stock
May 20, 2021 Buy 2 910 Johnson Chad Allen Stock Option (Right to Buy)
May 20, 2021 Buy 367 Johnson Chad Allen Common Stock
May 19, 2021 Buy 0 Schuchart Aaron Common Stock
May 06, 2021 Buy 45 000 Schuchart Aaron Stock Option (Right to Buy)
Apr 01, 2021 Sell 342 Powers Bradley J Common Stock
Apr 01, 2021 Sell 1 036 Mckew John C. Common Stock
Mar 01, 2021 Buy 8 500 Schuchart Aaron Stock Option (Right to Buy)
INSIDER POWER
97.523
Last 100 transactions
Buy: 751 206 | Sell: 15 950 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 97.523.

In total, the insiders bought 751 206 and sold 15 950 LUMO shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Lumos Pharma Inc.

Lumos Pharma. Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.... LUMO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT